The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.
about
Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy malesExploring the role of paraoxonases in the pathogenesis of coronary artery disease: a systematic review.Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patientsAddressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - a prospective study.Paraoxonase 1 (PON1) C/T-108 association with longitudinal mean arterial blood pressureAssociation Between Paraoxonase 2 Ser311Cys Polymorphism and Coronary Heart Disease Risk: A Meta-AnalysisAssociation of VAV2 and VAV3 polymorphisms with cardiovascular risk factors.Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery.Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.Association of PON1 and PON2 polymorphisms with PON1 activity and significant coronary stenosis in a Tunisian population.Phenotype distribution of the paraoxonase gene in patients with cardiac disease.Alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells mediated by morphine.Morphine-mediated alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells.PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans.Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.Association of Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population
P2860
Q33898495-1DEE14A1-F2B3-45E4-84EF-BC9410D0645AQ34685584-44177D12-917D-4964-9451-C81FDF891B9EQ34975825-2814AACF-A1D5-403C-BBAA-8CC52500D6B2Q35829214-90DEA9AB-A1C3-4BA4-9485-A0470A7BF093Q35990409-2D5E7C85-32E8-4BBC-8A28-D748610A8ED9Q36448919-08912C70-42F5-4F1C-B20A-DD5BF6D6ECB4Q37265237-E8CAEEE8-5E0E-45AD-819B-9D16667EB894Q37623525-45894940-2ECB-480F-9C44-A50601780855Q37707993-90D122F4-7A3B-4769-AAA8-0E53C7C33730Q39216431-A5D119C6-4F03-496E-88AE-D1DA92227135Q39391950-4D85B522-9634-43DF-9867-05A2571AD3ACQ41015173-5A20A7E1-D1E0-44A9-A2F0-35A566A5CE78Q42969977-04407AEC-147C-49A4-B6A5-B4A6D3DFC9BFQ42976646-39C61317-0D66-4BCA-AF02-50F9EDA7296EQ43107935-00A86657-C10F-406C-AA6E-311EEF63BCDDQ51033606-47E9AF69-DDC9-403D-8F69-1A8EB6E62386Q58700809-89A6A0BE-9F00-486E-B424-0ECC4B4829B1
P2860
The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The role of polymorphisms with ...... ovascular risk: a pilot study.
@en
The role of polymorphisms within paraoxonases
@nl
type
label
The role of polymorphisms with ...... ovascular risk: a pilot study.
@en
The role of polymorphisms within paraoxonases
@nl
prefLabel
The role of polymorphisms with ...... ovascular risk: a pilot study.
@en
The role of polymorphisms within paraoxonases
@nl
P2093
P2860
P356
P1433
P1476
The role of polymorphisms with ...... ovascular risk: a pilot study.
@en
P2093
Anna Gluba
Grzegorz Piotrowski
Jacek Rysz
Tadeusz Pietrucha
P2860
P304
P356
10.1177/0003319709351258
P577
2009-11-24T00:00:00Z